Asian MODY: Are we missing an important diagnosis?

Diabetic Medicine

Volumn 23, Issue 11, 2006, Pages 1257-1260

  Porter, J R ^a   Rangasami, J J ^b   Ellard, S ^c   Gloyn, A L ^d   Shields, B M ^c   Edwards, J ^b   Anderson, J M ^e   Shaw, N J ^f   Hattersley, A T ^c   Frayling, T M ^c   Plunkett, M ^f   Barrett, T G ^a  

^a BIRMINGHAM CHILDREN S HOSPITAL   (United Kingdom)

^b WEST MIDDLESEX UNIVERSITY HOSPITAL   (United Kingdom)

^c PENINSULA MEDICAL SCHOOL   (United Kingdom)

^d UNIVERSITY OF OXFORD   (United Kingdom)

^e ROYAL WOLVERHAMPTON HOSPITALS NHS TRUST   (United Kingdom)

^f CITY HOSPITAL   (United Kingdom)

Author keywords

Asian diabetes; Diagnosis; Genetics; MODY; Paediatrics

Indexed keywords

AUTOANTIBODY;

ARTICLE; ASIAN; CAUCASIAN; CHILD; CHILDHOOD DISEASE; DATA BASE; FAMILY; FAMILY HISTORY; FEMALE; GCK GENE; GENE; GENE MUTATION; GENE SEQUENCE; GENETIC EPIDEMIOLOGY; HETEROZYGOSITY; HNF1A GENE; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; MATURITY ONSET DIABETES MELLITUS; MATURITY ONSET DIABETES MELLITUS OF THE YOUNG; MONOGENIC DISORDER; PATIENT REFERRAL; PHENOTYPE; PREVALENCE; RACE DIFFERENCE; TCF1 GENE; UNITED KINGDOM;

ADOLESCENT; ASIAN CONTINENTAL ANCESTRY GROUP; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 2; FEMALE; GLUCOKINASE; HEPATOCYTE NUCLEAR FACTOR 1-ALPHA; HUMANS; MALE; MUTATION; PEDIGREE; POLYMORPHISM, GENETIC;

EID: 33750160717     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2006.01958.x     Document Type: Article

References (29)

1. Tattersall RB, Fajans SS. A difference between the inheritance of classical juvenile-onset and maturity-onset type diabetes of young people. Diabetes 1975; 24: 44-53.
2. Ehtisham S, Barrett TG, Shaw NJ. Type 2 diabetes mellitus in UK children an emerging problem. Diabet Med 2000; 17: 867-871.
3. Kousta E, Ellard S, Allen LI, Saker PJ, Huxtable SJ, Hattersley AT, et al. Glucokinase mutations in a phenotypically selected multiethnic group of women with a history of gestational diabetes. Diabet Med 2001; 18: 683-684.
4. Cockburn BN, Bermano G, Boodram LL, Teelucksingh S, Tsuchiya T, Mahabir D, et al. Insulin promoter factor-1 mutations and diabetes in Trinidad: identification of a novel diabetes-associated mutation (E224K) in an Indo-Trinidadian family. J Clin Endocrinol Metab 2004; 89: 971-978.
5. Venkatesan R, Ek J, Pedersen O, Viswanathan M, Torben H. Identification of Novel Mutations in the HNF-1alpha Gene in South Indian Patients with Maturity Onset Diabetes of the Young. 1-6- 2004. ADA Meeting abstracts. 2004.
6. Aguilar-Salinas CA, Reyes-Rodriguez E, Ordonez-Sanchez ML, Torres MA, Ramirez-Jimenez S, Dominguez-Lopez A, et al. Early-onset type 2 diabetes: metabolic and genetic characterization in the Mexican population. J Clin Endocrinol Metab 2001; 86: 220-226.
7. Hager J, Blanche H, Sun F, Vaxillaire NV, Poller W, Cohen D, et al. Six mutations in the glucokinase gene identified in MODY by using a nonradioactive sensitive screening technique. Diabetes 1994; 43: 730-733.
8. Shimada F, Makino H, Hashimoto N, Taira M, Seino S, Bell GI, et al. Type 2 (non-insulin-dependent) diabetes mellitus associated with a mutation of the glucokinase gene in a Japanese family. Diabetologia 1993; 36: 433-437.
9. Jap TS, Wu YC, Chiou JY, Kwok CF. A novel mutation in the hepatocyte nuclear factor-1alpha/MODY3 gene in Chinese subjects with early-onset Type 2 diabetes mellitus in Taiwan. Diabet Med 2000; 17: 390-393.
10. Hegele RA, Cao H, Harris SB, Hanley AJ, Zinman B. Hepatocyte nuclear factor-1 alpha G319S. A private mutation in Oji-Cree associated with type 2 diabetes. Diabetes Care 1999; 22: 524.
11. Ehtisham S, Hattersley AT, Dunger DB, Barrett TG. First UK survey of paediatric type 2 diabetes and MODY. Arch Dis Child 2004; 89: 526-529.
12. Smith A, Jefferson I. The National Paediatric Diabetes Register/Audit. Diabet Med 2001; 18: 409-412.
13. Statistics OoN. Census Report 2001. London: Office of National Statistics. 2001.
14. Bingley PJ, Bonifacio E, Williams AJ, Genovese S, Bottazzo GF, Gale EA. Prediction of IDDM in the general population: strategies based on combinations of autoantibody markers. Diabetes 1997; 46: 1701-1710.
15. Pearson ER, Velho G, Clark P, Stride A, Shepherd M, Frayling TM, et al. Beta-cell genes and diabetes: quantitative and qualitative differences in the pathophysiology of hepatic nuclear factor-1alpha and glucokinase mutations. Diabetes 2001; 50: S101-S107.
16. Porter JR, Shaw NJ, Barrett TG, Hattersley AT, Ellard S, Gloyn AL. Permanent neonatal diabetes in an Asian infant. J Pediatr 2005; 146: 131-133.
17. Njolstad PR, Sovik O, Cuesta-Munoz A, Bjorkhaug L, Massa O, Barbetti F, et al. Neonatal diabetes mellitus due to complete glucokinase deficiency. N Engl J Med 2001; 344: 1588-1592.
18. Njolstad PR, Sagen JV, Bjorkhaug L, Odili S, Shehadeh N, Bakry D, et al. Permanent neonatal diabetes caused by glucokinase deficiency: inborn error of the glucose-insulin signaling pathway. Diabetes 2003; 52: 2854-2860.
19. McKeigue PM, Shah B, Marmot MG. Relation of central obesity and insulin resistance with high diabetes prevalence and cardiovascular risk in South Asians. Lancet 1991; 337: 382-386.
20. Green A, Patterson CC. Trends in the incidence of childhood-onset diabetes in Europe 1989-1998. Diabetologia 2001; 44: B3-B8.
21. Feltbower RG, Bodansky HJ, McKinney PA, Houghton J, Stephenson CR, Haigh D. Trends in the incidence of childhood diabetes in south Asians and other children in Bradford, UK. Diabet Med 2002; 19: 162-166.
22. British Paediatric Surveillance Unit. 19th Annual Report. London: BPSU 2005: 25-27.
23. Ehtisham S, Crabtree N, Clark P, Shaw N, Barrett T. Ethnic differences in insulin resistance and body composition in United Kingdom adolescents. J Clin Endocrinol Metab 2005; 90: 3963-3969.
24. Shepherd M, Ellis I, Ahmad AM, Todd PJ, Bowen-Jones D, Mannion G, et al. Predictive genetic testing in maturity-onset diabetes of the young (MODY). Diabet Med 2001; 18: 417-421.
25. Rowe RE, Garcia J, Davidson LL. Social and ethnic inequalities in the offer and uptake of prenatal screening and diagnosis in the UK: a systematic review. Public Health 2004; 118: 177-189.
26. Pearson ER, Liddell WG, Shepherd M, Corrall RJ, Hattersley AT. Sensitivity to sulphonylureas in patients with hepatocyte nuclear factor-1 gene mutations: evidence for pharmacogenetics in diabetes. Diabet Med 2000; 17: 543-545.
27. Shepherd M, Pearson ER, Houghton J, Salt G, Ellard S, Hattersley AT. No deterioration in glycemic control in HNF-1alpha maturity-onset diabetes of the young following transfer from long-term insulin to sulphonylureas. Diabetes Care 2003; 26: 3191-3192.
28. Stride A, Hattersley AT. Different genes, different diabetes: lessons from maturity-onset diabetes of the young. Ann Med 2002; 34: 207-216.
29. Jones KL, Arslanian S, Peterokova VA, Park JS, Tomlinson MJ. Effect of metformin in pediatric patients with type 2 diabetes: a randomized controlled trial. Diabetes Care 2002; 25: 89-94.